Pérez-González Mariana Z, Siordia-Reyes A Georgina, Damián-Nava Patricia, Hernández-Ortega Simón, Macías-Rubalcava Martha L, Jiménez-Arellanes María A
Unidad, Investigación Médica en Farmacología, Hospital de Especialidades, CMN-SXXI, IMSS. Av. Cuauhtémoc 330, Col. Doctores, 06720 Ciudad de México (CDMX), Mexico.
División Histopatología, Hospital de Pediatría, CMN-SXXI, Instituto Mexicano del Seguro Social (IMSS). Av. Cuauhtémoc 330, Col. Doctores, 06720 CDMX, Mexico.
Evid Based Complement Alternat Med. 2018 Jul 25;2018:3896517. doi: 10.1155/2018/3896517. eCollection 2018.
Previous report described that CHCl:MeOH extract of leaves and pure compounds (moretenol, moretenyl acetate, kaempferol-3,7-dimethyl ether, and 5-hydroxy-7-3',4'-trimethoxyflavanone) showed important topical and systemic anti-inflammatory activity in acute model, as well as antimycobacterial and antiprotozoal activities. In this paper, we describe the hepatoprotective and anti-inflammatory effects of the CHCl:MeOH extract in chronic model and the isolation of additional compounds (moretenone and lupeol acetate). The hepatoprotective activity was determined at 39 days using Balb/c mice with liver damage induced with an antitubercular drug (RIF/INH/PZA). The anti-inflammatory activity was evaluated in a chronic model induced with CFA and in two acute models (TPA and carrageenan). In addition, moretenone and lupeol acetate were isolated and identified by spectroscopic data. Lupeol acetate is a main compound present in fractions 14-42, and this fraction was the majority fraction from the extract; from this moretenone was obtained. In animals with liver damage, the extract at 200 and 400 mg/kg induced better body weight gain with respect to positive control (Silymarin); in addition, the mice that received the extract at 200 mg/kg and Silymarin exhibited slight steatosis; however, the animals' livers at 400 mg/kg did not show steatosis. The extract and fractions 14-42 showed a good anti-inflammatory activity by TPA model (DE = 1.58 and 1.48 mg/ear) and by carrageenan model (DE = 351.53 and 50.11 mg/kg). In the chronic inflammatory test, the extract at three doses revealed a similar effect to that of phenylbutazone, although the body weight gain was better in animals that received the extract at 900 mg/kg. . The CHCl:MeOH extract showed significant anti-inflammatory and good hepatoprotective effect on chronic models. The fraction containing moretenone and lupeol acetate as main compounds was more active than extract in both acute models of inflammation.
甲醇提取物以及纯化合物(莫雷烯醇、莫雷烯乙酸酯、山奈酚-3,7-二甲醚和5-羟基-7-3',4'-三甲氧基黄酮)在急性模型中显示出重要的局部和全身抗炎活性,以及抗分枝杆菌和抗原虫活性。在本文中,我们描述了氯仿:甲醇提取物在慢性模型中的肝保护和抗炎作用以及其他化合物(莫雷烯酮和乙酸羽扇豆醇酯)的分离。使用由抗结核药物(利福平/异烟肼/吡嗪酰胺)诱导肝损伤的Balb/c小鼠在第39天测定肝保护活性。在由弗氏完全佐剂诱导的慢性模型以及两个急性模型(佛波酯和角叉菜胶)中评估抗炎活性。此外,通过光谱数据分离并鉴定了莫雷烯酮和乙酸羽扇豆醇酯。乙酸羽扇豆醇酯是14-42馏分中的主要化合物,该馏分是提取物中的主要馏分;由此获得了莫雷烯酮。在肝损伤动物中,200和400mg/kg的提取物相对于阳性对照(水飞蓟宾)诱导了更好的体重增加;此外,接受200mg/kg提取物和水飞蓟宾的小鼠表现出轻微的脂肪变性;然而,400mg/kg剂量组动物的肝脏未显示脂肪变性。提取物和14-42馏分在佛波酯模型(DE = 1.58和1.48mg/耳)和角叉菜胶模型(DE = 351.53和50.11mg/kg)中显示出良好的抗炎活性。在慢性炎症试验中,三个剂量的提取物显示出与苯基丁氮酮相似的效果,尽管接受900mg/kg提取物的动物体重增加更好。氯仿:甲醇提取物对慢性模型显示出显著的抗炎和良好的肝保护作用。以莫雷烯酮和乙酸羽扇豆醇酯为主要化合物的馏分在两种急性炎症模型中比提取物更具活性。